SCHEMBL13309461

SCHEMBL13309461

CBc1cnn2c(Nc3ccc(S(=O)(=O)Nc4cc(-c5ccccc5)nc5c(C)cnn45)cc3)cc(-c3ccccc3)nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ TP53 P04637 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ GSK3B P49841 3/20 0.43
▸ MAPT P10636 6/20 0.42
▸ PKM P14618 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13308747 0.90 KDM4E (0.44) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL13309052 0.88 KDM4E (0.43) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL13309241 0.85 GSK3B (0.46) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL13309179 0.82 GSK3B (0.48) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL14528898 0.82 KDM4E (0.41) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL13885070 0.81 GSK3B (0.60) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL13309102 0.81 CA12 (0.45) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL14528759 0.80 IKBKB (0.42) KDM4ETP53POLBGSK3BMAPT
SCHEMBL13309058 0.79 MEN1 (0.43) KDM4EALDH1A1TP53POLBGSK3B
SCHEMBL14529038 0.79 KDM4E (0.46) KDM4EALDH1A1TP53POLBGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934224-B1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORP (US) 2010-06-09 — — EP disclosed
Send feedback